1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications
1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid having the following structural formula A pharmaceutical composition for treating diabetes mellitus complications comprises an active agent and a pharmaceutical base material, wherein the active agent is a compound selected from the group consisti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KIRICHEK LORA M MELNIK IGOR M KAMINSKY LEONID A MOKHORT NIKOLAI A TRONKO NIKOLAI D OBROSOVA IRINA G GORDIENKO VADIM M ZBOROVSKY JURY L TKACHUK JURY V EFIMOV ANDREI S EFIMOVA ELENA K STANINETS VASILY I |
| description | 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid having the following structural formula A pharmaceutical composition for treating diabetes mellitus complications comprises an active agent and a pharmaceutical base material, wherein the active agent is a compound selected from the group consisting of 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, and the sodium and potassium salts thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US4598081A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US4598081A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US4598081A3</originalsourceid><addsrcrecordid>eNqFjcFKBDEQROfiQdRvsI-7sAHHUViPIsrc1fPSk_TsNnTSMekB1w_z-4yLd09FFa-qzrvvfjO4wPqprh_dROlrFWjNVT8WTiqcyN2uhnEN02LHwh7Qc9hAPmCJ6FV0zx5Fji33lA0nIagoVsEOVEhnwBTAa8xa2VhTbSYZcuK0_2UaHQlmLWCF0CIlg9YKjBMZVYgkwrbU04a0s9PIZXc2o1S6-tOL7vrl-e1pdJR1RzWjp0S2e3-9u3_Y3mz7x-F_4gcaeFxV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications</title><source>esp@cenet</source><creator>KIRICHEK; LORA M ; MELNIK; IGOR M ; KAMINSKY; LEONID A ; MOKHORT; NIKOLAI A ; TRONKO; NIKOLAI D ; OBROSOVA; IRINA G ; GORDIENKO; VADIM M ; ZBOROVSKY; JURY L ; TKACHUK; JURY V ; EFIMOV; ANDREI S ; EFIMOVA; ELENA K ; STANINETS; VASILY I</creator><creatorcontrib>KIRICHEK; LORA M ; MELNIK; IGOR M ; KAMINSKY; LEONID A ; MOKHORT; NIKOLAI A ; TRONKO; NIKOLAI D ; OBROSOVA; IRINA G ; GORDIENKO; VADIM M ; ZBOROVSKY; JURY L ; TKACHUK; JURY V ; EFIMOV; ANDREI S ; EFIMOVA; ELENA K ; STANINETS; VASILY I</creatorcontrib><description>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid having the following structural formula A pharmaceutical composition for treating diabetes mellitus complications comprises an active agent and a pharmaceutical base material, wherein the active agent is a compound selected from the group consisting of 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, and the sodium and potassium salts thereof.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>1986</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19860701&DB=EPODOC&CC=US&NR=4598081A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19860701&DB=EPODOC&CC=US&NR=4598081A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KIRICHEK; LORA M</creatorcontrib><creatorcontrib>MELNIK; IGOR M</creatorcontrib><creatorcontrib>KAMINSKY; LEONID A</creatorcontrib><creatorcontrib>MOKHORT; NIKOLAI A</creatorcontrib><creatorcontrib>TRONKO; NIKOLAI D</creatorcontrib><creatorcontrib>OBROSOVA; IRINA G</creatorcontrib><creatorcontrib>GORDIENKO; VADIM M</creatorcontrib><creatorcontrib>ZBOROVSKY; JURY L</creatorcontrib><creatorcontrib>TKACHUK; JURY V</creatorcontrib><creatorcontrib>EFIMOV; ANDREI S</creatorcontrib><creatorcontrib>EFIMOVA; ELENA K</creatorcontrib><creatorcontrib>STANINETS; VASILY I</creatorcontrib><title>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications</title><description>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid having the following structural formula A pharmaceutical composition for treating diabetes mellitus complications comprises an active agent and a pharmaceutical base material, wherein the active agent is a compound selected from the group consisting of 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, and the sodium and potassium salts thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1986</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjcFKBDEQROfiQdRvsI-7sAHHUViPIsrc1fPSk_TsNnTSMekB1w_z-4yLd09FFa-qzrvvfjO4wPqprh_dROlrFWjNVT8WTiqcyN2uhnEN02LHwh7Qc9hAPmCJ6FV0zx5Fji33lA0nIagoVsEOVEhnwBTAa8xa2VhTbSYZcuK0_2UaHQlmLWCF0CIlg9YKjBMZVYgkwrbU04a0s9PIZXc2o1S6-tOL7vrl-e1pdJR1RzWjp0S2e3-9u3_Y3mz7x-F_4gcaeFxV</recordid><startdate>19860701</startdate><enddate>19860701</enddate><creator>KIRICHEK; LORA M</creator><creator>MELNIK; IGOR M</creator><creator>KAMINSKY; LEONID A</creator><creator>MOKHORT; NIKOLAI A</creator><creator>TRONKO; NIKOLAI D</creator><creator>OBROSOVA; IRINA G</creator><creator>GORDIENKO; VADIM M</creator><creator>ZBOROVSKY; JURY L</creator><creator>TKACHUK; JURY V</creator><creator>EFIMOV; ANDREI S</creator><creator>EFIMOVA; ELENA K</creator><creator>STANINETS; VASILY I</creator><scope>EVB</scope></search><sort><creationdate>19860701</creationdate><title>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications</title><author>KIRICHEK; LORA M ; MELNIK; IGOR M ; KAMINSKY; LEONID A ; MOKHORT; NIKOLAI A ; TRONKO; NIKOLAI D ; OBROSOVA; IRINA G ; GORDIENKO; VADIM M ; ZBOROVSKY; JURY L ; TKACHUK; JURY V ; EFIMOV; ANDREI S ; EFIMOVA; ELENA K ; STANINETS; VASILY I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US4598081A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1986</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>KIRICHEK; LORA M</creatorcontrib><creatorcontrib>MELNIK; IGOR M</creatorcontrib><creatorcontrib>KAMINSKY; LEONID A</creatorcontrib><creatorcontrib>MOKHORT; NIKOLAI A</creatorcontrib><creatorcontrib>TRONKO; NIKOLAI D</creatorcontrib><creatorcontrib>OBROSOVA; IRINA G</creatorcontrib><creatorcontrib>GORDIENKO; VADIM M</creatorcontrib><creatorcontrib>ZBOROVSKY; JURY L</creatorcontrib><creatorcontrib>TKACHUK; JURY V</creatorcontrib><creatorcontrib>EFIMOV; ANDREI S</creatorcontrib><creatorcontrib>EFIMOVA; ELENA K</creatorcontrib><creatorcontrib>STANINETS; VASILY I</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KIRICHEK; LORA M</au><au>MELNIK; IGOR M</au><au>KAMINSKY; LEONID A</au><au>MOKHORT; NIKOLAI A</au><au>TRONKO; NIKOLAI D</au><au>OBROSOVA; IRINA G</au><au>GORDIENKO; VADIM M</au><au>ZBOROVSKY; JURY L</au><au>TKACHUK; JURY V</au><au>EFIMOV; ANDREI S</au><au>EFIMOVA; ELENA K</au><au>STANINETS; VASILY I</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications</title><date>1986-07-01</date><risdate>1986</risdate><abstract>1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid having the following structural formula A pharmaceutical composition for treating diabetes mellitus complications comprises an active agent and a pharmaceutical base material, wherein the active agent is a compound selected from the group consisting of 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, and the sodium and potassium salts thereof.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US4598081A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacologically acceptable salts thereof and compositions containing the same for treatment of diabetes mellitus complications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T08%3A09%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KIRICHEK;%20LORA%20M&rft.date=1986-07-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS4598081A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |